

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 5.37868484 |
| 2 | proteasome assembly (GO:0043248) | 4.67768139 |
| 3 | DNA deamination (GO:0045006) | 4.27723793 |
| 4 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.08004340 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 3.97559299 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.97559299 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 3.94077401 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.94077401 |
| 9 | protein deneddylation (GO:0000338) | 3.89928553 |
| 10 | regulation of mitochondrial translation (GO:0070129) | 3.89906710 |
| 11 | branched-chain amino acid catabolic process (GO:0009083) | 3.88724425 |
| 12 | metallo-sulfur cluster assembly (GO:0031163) | 3.87902505 |
| 13 | iron-sulfur cluster assembly (GO:0016226) | 3.87902505 |
| 14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.84476187 |
| 15 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.77605600 |
| 16 | response to interferon-beta (GO:0035456) | 3.77397838 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.77040230 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 3.64932566 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 3.64932566 |
| 20 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.63212980 |
| 21 | signal peptide processing (GO:0006465) | 3.56266379 |
| 22 | cullin deneddylation (GO:0010388) | 3.50228857 |
| 23 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.48443708 |
| 24 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.47211498 |
| 25 | piRNA metabolic process (GO:0034587) | 3.42532793 |
| 26 | xenobiotic catabolic process (GO:0042178) | 3.40785343 |
| 27 | GMP metabolic process (GO:0046037) | 3.40777205 |
| 28 | protein neddylation (GO:0045116) | 3.39258061 |
| 29 | respiratory electron transport chain (GO:0022904) | 3.38550541 |
| 30 | aldehyde catabolic process (GO:0046185) | 3.33041669 |
| 31 | electron transport chain (GO:0022900) | 3.31537665 |
| 32 | GDP-mannose metabolic process (GO:0019673) | 3.29525128 |
| 33 | endosome to melanosome transport (GO:0035646) | 3.29448733 |
| 34 | endosome to pigment granule transport (GO:0043485) | 3.29448733 |
| 35 | L-methionine salvage (GO:0071267) | 3.29142899 |
| 36 | L-methionine biosynthetic process (GO:0071265) | 3.29142899 |
| 37 | amino acid salvage (GO:0043102) | 3.29142899 |
| 38 | oxidative phosphorylation (GO:0006119) | 3.27255646 |
| 39 | GPI anchor biosynthetic process (GO:0006506) | 3.24999887 |
| 40 | platelet dense granule organization (GO:0060155) | 3.23553315 |
| 41 | meiotic chromosome segregation (GO:0045132) | 3.22005763 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.19151637 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.15989380 |
| 44 | ATP synthesis coupled proton transport (GO:0015986) | 3.14743293 |
| 45 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.14743293 |
| 46 | branched-chain amino acid metabolic process (GO:0009081) | 3.11069913 |
| 47 | cellular response to interferon-beta (GO:0035458) | 3.10432188 |
| 48 | ribosomal small subunit assembly (GO:0000028) | 3.08222115 |
| 49 | C-terminal protein lipidation (GO:0006501) | 3.07763280 |
| 50 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.07358412 |
| 51 | daunorubicin metabolic process (GO:0044597) | 3.05910584 |
| 52 | polyketide metabolic process (GO:0030638) | 3.05910584 |
| 53 | doxorubicin metabolic process (GO:0044598) | 3.05910584 |
| 54 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.05128850 |
| 55 | purine-containing compound salvage (GO:0043101) | 3.02263190 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 3.01484476 |
| 57 | purine nucleobase biosynthetic process (GO:0009113) | 3.00666135 |
| 58 | maturation of 5.8S rRNA (GO:0000460) | 2.99689835 |
| 59 | tricarboxylic acid cycle (GO:0006099) | 2.97735198 |
| 60 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.95772485 |
| 61 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.95541666 |
| 62 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.95508505 |
| 63 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.92443032 |
| 64 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.92443032 |
| 65 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.92443032 |
| 66 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.91141395 |
| 67 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.91141395 |
| 68 | telomere maintenance via recombination (GO:0000722) | 2.90701660 |
| 69 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.90449113 |
| 70 | single strand break repair (GO:0000012) | 2.89689081 |
| 71 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.89550841 |
| 72 | regulation of helicase activity (GO:0051095) | 2.88928443 |
| 73 | respiratory chain complex IV assembly (GO:0008535) | 2.88270989 |
| 74 | protein targeting to mitochondrion (GO:0006626) | 2.87866055 |
| 75 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.82598686 |
| 76 | GPI anchor metabolic process (GO:0006505) | 2.80315053 |
| 77 | positive regulation of actin filament depolymerization (GO:0030836) | 2.80210704 |
| 78 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.79586921 |
| 79 | ribosome assembly (GO:0042255) | 2.78062618 |
| 80 | regulation of cellular amine metabolic process (GO:0033238) | 2.77409779 |
| 81 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.76690422 |
| 82 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.75570914 |
| 83 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.75570914 |
| 84 | chaperone-mediated protein transport (GO:0072321) | 2.74859429 |
| 85 | ribosomal large subunit biogenesis (GO:0042273) | 2.74340000 |
| 86 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.73532945 |
| 87 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.72971468 |
| 88 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.72079311 |
| 89 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.70296395 |
| 90 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.70088260 |
| 91 | cell redox homeostasis (GO:0045454) | 2.69996747 |
| 92 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.69604697 |
| 93 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.69556212 |
| 94 | cytochrome complex assembly (GO:0017004) | 2.68635953 |
| 95 | rRNA modification (GO:0000154) | 2.68277460 |
| 96 | methionine biosynthetic process (GO:0009086) | 2.67864996 |
| 97 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.67502787 |
| 98 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.67502787 |
| 99 | chromatin remodeling at centromere (GO:0031055) | 2.66319224 |
| 100 | CENP-A containing nucleosome assembly (GO:0034080) | 2.66089014 |
| 101 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.65464318 |
| 102 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.65381595 |
| 103 | C-terminal protein amino acid modification (GO:0018410) | 2.65080796 |
| 104 | quinone metabolic process (GO:1901661) | 2.64741745 |
| 105 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.64092397 |
| 106 | nucleoside salvage (GO:0043174) | 2.62957809 |
| 107 | blood coagulation, intrinsic pathway (GO:0007597) | 2.61640621 |
| 108 | response to interferon-alpha (GO:0035455) | 2.61593252 |
| 109 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.61483375 |
| 110 | negative regulation of ligase activity (GO:0051352) | 2.61483375 |
| 111 | neutrophil activation involved in immune response (GO:0002283) | 2.61103707 |
| 112 | positive regulation of cell cycle arrest (GO:0071158) | 2.60373048 |
| 113 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.59785590 |
| 114 | galactose catabolic process (GO:0019388) | 2.59644794 |
| 115 | rRNA methylation (GO:0031167) | 2.58909153 |
| 116 | establishment of protein localization to mitochondrion (GO:0072655) | 2.57896751 |
| 117 | DNA methylation involved in gamete generation (GO:0043046) | 2.57697681 |
| 118 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.57329876 |
| 119 | regulation of ligase activity (GO:0051340) | 2.57011141 |
| 120 | mannosylation (GO:0097502) | 2.56354327 |
| 121 | 7-methylguanosine mRNA capping (GO:0006370) | 2.54973754 |
| 122 | cellular aldehyde metabolic process (GO:0006081) | 2.54812947 |
| 123 | AMP metabolic process (GO:0046033) | 2.54205440 |
| 124 | aerobic respiration (GO:0009060) | 2.52948560 |
| 125 | mitochondrial DNA replication (GO:0006264) | 2.52587889 |
| 126 | regulation of metalloenzyme activity (GO:0048552) | 2.51546907 |
| 127 | glyoxylate metabolic process (GO:0046487) | 2.49941155 |
| 128 | RNA capping (GO:0036260) | 2.49816749 |
| 129 | 7-methylguanosine RNA capping (GO:0009452) | 2.49816749 |
| 130 | mitotic recombination (GO:0006312) | 2.47769816 |
| 131 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.47328995 |
| 132 | cellular metabolic compound salvage (GO:0043094) | 2.46341695 |
| 133 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.46075047 |
| 134 | metaphase plate congression (GO:0051310) | 2.45912230 |
| 135 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.44953481 |
| 136 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.44240430 |
| 137 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.44181822 |
| 138 | protein complex biogenesis (GO:0070271) | 2.43394184 |
| 139 | positive regulation of ligase activity (GO:0051351) | 2.42979970 |
| 140 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.42048456 |
| 141 | DNA strand elongation (GO:0022616) | 2.41176436 |
| 142 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.40028988 |
| 143 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.40028988 |
| 144 | regulation of RIG-I signaling pathway (GO:0039535) | 2.38863648 |
| 145 | nucleobase biosynthetic process (GO:0046112) | 2.38063167 |
| 146 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.36333016 |
| 147 | termination of RNA polymerase III transcription (GO:0006386) | 2.36333016 |
| 148 | mitotic metaphase plate congression (GO:0007080) | 2.34917376 |
| 149 | phagocytosis, engulfment (GO:0006911) | 2.34815653 |
| 150 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.33433646 |
| 151 | leukocyte mediated cytotoxicity (GO:0001909) | 2.32934525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.71415578 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.41674103 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.38486846 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.25530777 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94252240 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.91498122 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.84261710 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.81068272 |
| 9 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.73313942 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.70496511 |
| 11 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.66703509 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.63011226 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.49706216 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.46572862 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.46052356 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.45821469 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.45777974 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.43977776 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.40831752 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.35319098 |
| 21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.33527389 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31199186 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.30332408 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.25879541 |
| 25 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24678912 |
| 26 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.23752604 |
| 27 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.20120389 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.19342706 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14800895 |
| 30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.08506142 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.01809732 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00693706 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.00246042 |
| 34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.93522724 |
| 35 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.92024719 |
| 36 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89802501 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.87176956 |
| 38 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.86928704 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.86054242 |
| 40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.81403415 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79505664 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78566271 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.78040142 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.73804429 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.73731952 |
| 46 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.69808051 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69264663 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56254866 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.55636164 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.54221215 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53365199 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52536402 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52176700 |
| 54 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.48713388 |
| 55 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.47671556 |
| 56 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.45533744 |
| 57 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.44800907 |
| 58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42393418 |
| 59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40865693 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40460597 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40179948 |
| 62 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.38993778 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.38708906 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38457094 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33588633 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33412976 |
| 67 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29947740 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29148943 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28849288 |
| 70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.22443089 |
| 71 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20000473 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.19932286 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19906045 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19898192 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18751156 |
| 76 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.18698319 |
| 77 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.18614934 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18287959 |
| 79 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16596995 |
| 80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16550689 |
| 81 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.15271277 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14590683 |
| 83 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.12107036 |
| 84 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.11569427 |
| 85 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.10318894 |
| 86 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09998651 |
| 87 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09052553 |
| 88 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.08897786 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07962099 |
| 90 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.07958690 |
| 91 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06531689 |
| 92 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06378033 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05097627 |
| 94 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04603215 |
| 95 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04397205 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03971866 |
| 97 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.03558597 |
| 98 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02204043 |
| 99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02058220 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01599436 |
| 101 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01126137 |
| 102 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00982163 |
| 103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00672090 |
| 104 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97734851 |
| 105 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97636379 |
| 106 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.96980168 |
| 107 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96621833 |
| 108 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.96455059 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96272949 |
| 110 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94569210 |
| 111 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.94480299 |
| 112 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93078424 |
| 113 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92371340 |
| 114 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.91841437 |
| 115 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.91841437 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90918922 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90026084 |
| 118 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.88994977 |
| 119 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88883289 |
| 120 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88539034 |
| 121 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88351884 |
| 122 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88030871 |
| 123 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86284341 |
| 124 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85881980 |
| 125 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.85836641 |
| 126 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85705826 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85534937 |
| 128 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84781809 |
| 129 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84122513 |
| 130 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.82993429 |
| 131 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82325088 |
| 132 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80371535 |
| 133 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.80221060 |
| 134 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.80221060 |
| 135 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.79480612 |
| 136 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.79069829 |
| 137 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.77024269 |
| 138 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.76908043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.84831767 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.68954552 |
| 3 | MP0006054_spinal_hemorrhage | 3.67702158 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.03068746 |
| 5 | MP0003186_abnormal_redox_activity | 2.96431445 |
| 6 | MP0005360_urolithiasis | 2.94353092 |
| 7 | MP0009697_abnormal_copulation | 2.86824115 |
| 8 | MP0000372_irregular_coat_pigmentation | 2.63658265 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.62034932 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.58480937 |
| 11 | MP0005365_abnormal_bile_salt | 2.55773182 |
| 12 | MP0004782_abnormal_surfactant_physiolog | 2.54585175 |
| 13 | MP0008058_abnormal_DNA_repair | 2.52272278 |
| 14 | MP0009785_altered_susceptibility_to | 2.51244627 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.49807056 |
| 16 | MP0008438_abnormal_cutaneous_collagen | 2.38455157 |
| 17 | MP0005332_abnormal_amino_acid | 2.37408626 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.35671806 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.32792637 |
| 20 | MP0003656_abnormal_erythrocyte_physiolo | 2.29961420 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.27759332 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 2.19637908 |
| 23 | MP0010094_abnormal_chromosome_stability | 2.19068416 |
| 24 | MP0003436_decreased_susceptibility_to | 2.18255614 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.11170363 |
| 26 | MP0003195_calcinosis | 2.01189606 |
| 27 | MP0005670_abnormal_white_adipose | 2.00453827 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.96932132 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 1.96058530 |
| 30 | MP0004147_increased_porphyrin_level | 1.93509482 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.89900044 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.88936228 |
| 33 | MP0008007_abnormal_cellular_replicative | 1.85070602 |
| 34 | MP0001661_extended_life_span | 1.82204854 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.79827652 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.79175045 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.78742097 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.75019300 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.73104831 |
| 40 | MP0006082_CNS_inflammation | 1.71532832 |
| 41 | MP0003077_abnormal_cell_cycle | 1.70438274 |
| 42 | MP0004272_abnormal_basement_membrane | 1.69929550 |
| 43 | MP0009840_abnormal_foam_cell | 1.66664439 |
| 44 | MP0002419_abnormal_innate_immunity | 1.65975902 |
| 45 | MP0001666_abnormal_nutrient_absorption | 1.65294600 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.60041878 |
| 47 | MP0002405_respiratory_system_inflammati | 1.58214955 |
| 48 | MP0005025_abnormal_response_to | 1.56899354 |
| 49 | MP0003011_delayed_dark_adaptation | 1.51606641 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.47665414 |
| 51 | MP0005671_abnormal_response_to | 1.42946832 |
| 52 | MP0002723_abnormal_immune_serum | 1.42890539 |
| 53 | MP0003786_premature_aging | 1.41687574 |
| 54 | MP0000343_altered_response_to | 1.41606434 |
| 55 | MP0003868_abnormal_feces_composition | 1.38946600 |
| 56 | MP0003718_maternal_effect | 1.38523921 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.37767400 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.36939764 |
| 59 | MP0001800_abnormal_humoral_immune | 1.35326792 |
| 60 | MP0002163_abnormal_gland_morphology | 1.33591321 |
| 61 | MP0002938_white_spotting | 1.32380164 |
| 62 | MP0003252_abnormal_bile_duct | 1.32052733 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.31608628 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.31542260 |
| 65 | MP0001819_abnormal_immune_cell | 1.30761105 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.29038448 |
| 67 | MP0001756_abnormal_urination | 1.28799892 |
| 68 | MP0003724_increased_susceptibility_to | 1.28420684 |
| 69 | MP0008469_abnormal_protein_level | 1.25702226 |
| 70 | MP0000490_abnormal_crypts_of | 1.25486043 |
| 71 | MP0001984_abnormal_olfaction | 1.24451428 |
| 72 | MP0002118_abnormal_lipid_homeostasis | 1.24150775 |
| 73 | MP0001764_abnormal_homeostasis | 1.22011297 |
| 74 | MP0000358_abnormal_cell_content/ | 1.19050902 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.18226070 |
| 76 | MP0000639_abnormal_adrenal_gland | 1.18095000 |
| 77 | MP0009764_decreased_sensitivity_to | 1.18034757 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.16630455 |
| 79 | MP0003943_abnormal_hepatobiliary_system | 1.16507244 |
| 80 | MP0002132_abnormal_respiratory_system | 1.15642857 |
| 81 | MP0002398_abnormal_bone_marrow | 1.15147848 |
| 82 | MP0008260_abnormal_autophagy | 1.15080701 |
| 83 | MP0001545_abnormal_hematopoietic_system | 1.15031065 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 1.15031065 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.14611467 |
| 86 | MP0000716_abnormal_immune_system | 1.14572385 |
| 87 | MP0008877_abnormal_DNA_methylation | 1.14183279 |
| 88 | MP0004134_abnormal_chest_morphology | 1.13743228 |
| 89 | MP0008932_abnormal_embryonic_tissue | 1.13717948 |
| 90 | MP0000685_abnormal_immune_system | 1.13151742 |
| 91 | MP0002722_abnormal_immune_system | 1.12964971 |
| 92 | MP0001533_abnormal_skeleton_physiology | 1.12599559 |
| 93 | MP0002210_abnormal_sex_determination | 1.12571577 |
| 94 | MP0009643_abnormal_urine_homeostasis | 1.12351482 |
| 95 | MP0001929_abnormal_gametogenesis | 1.11276168 |
| 96 | MP0001119_abnormal_female_reproductive | 1.10847088 |
| 97 | MP0001529_abnormal_vocalization | 1.09877063 |
| 98 | MP0005165_increased_susceptibility_to | 1.08729884 |
| 99 | MP0003763_abnormal_thymus_physiology | 1.07895309 |
| 100 | MP0003646_muscle_fatigue | 1.05982419 |
| 101 | MP0002429_abnormal_blood_cell | 1.05700206 |
| 102 | MP0002090_abnormal_vision | 1.05367032 |
| 103 | MP0005410_abnormal_fertilization | 1.05275682 |
| 104 | MP0008057_abnormal_DNA_replication | 1.05262156 |
| 105 | MP0002006_tumorigenesis | 1.04249989 |
| 106 | MP0001542_abnormal_bone_strength | 1.02234565 |
| 107 | MP0000003_abnormal_adipose_tissue | 1.02208097 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 1.00586578 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.99790101 |
| 110 | MP0002009_preneoplasia | 0.96609017 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.96553774 |
| 112 | MP0005503_abnormal_tendon_morphology | 0.95982213 |
| 113 | MP0003075_altered_response_to | 0.95926137 |
| 114 | MP0000609_abnormal_liver_physiology | 0.94949955 |
| 115 | MP0001145_abnormal_male_reproductive | 0.94105914 |
| 116 | MP0001790_abnormal_immune_system | 0.94061672 |
| 117 | MP0005387_immune_system_phenotype | 0.94061672 |
| 118 | MP0005390_skeleton_phenotype | 0.93621385 |
| 119 | MP0005253_abnormal_eye_physiology | 0.92427147 |
| 120 | MP0003111_abnormal_nucleus_morphology | 0.91933670 |
| 121 | MP0005330_cardiomyopathy | 0.91605576 |
| 122 | MP0000653_abnormal_sex_gland | 0.91012060 |
| 123 | MP0006072_abnormal_retinal_apoptosis | 0.90892973 |
| 124 | MP0000598_abnormal_liver_morphology | 0.90504993 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.90427802 |
| 126 | MP0010155_abnormal_intestine_physiology | 0.89034653 |
| 127 | MP0002638_abnormal_pupillary_reflex | 0.88843821 |
| 128 | MP0002019_abnormal_tumor_incidence | 0.88728163 |
| 129 | MP0001853_heart_inflammation | 0.88171802 |
| 130 | MP0001905_abnormal_dopamine_level | 0.87230494 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.86851003 |
| 132 | MP0004215_abnormal_myocardial_fiber | 0.86245594 |
| 133 | MP0002837_dystrophic_cardiac_calcinosis | 0.85895020 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85399882 |
| 135 | MP0008872_abnormal_physiological_respon | 0.84229266 |
| 136 | MP0002277_abnormal_respiratory_mucosa | 0.84003173 |
| 137 | MP0006292_abnormal_olfactory_placode | 0.83202711 |
| 138 | MP0005379_endocrine/exocrine_gland_phen | 0.80528168 |
| 139 | MP0010386_abnormal_urinary_bladder | 0.79863057 |
| 140 | MP0005367_renal/urinary_system_phenotyp | 0.77963947 |
| 141 | MP0000516_abnormal_urinary_system | 0.77963947 |
| 142 | MP0008004_abnormal_stomach_pH | 0.77643183 |
| 143 | MP0002166_altered_tumor_susceptibility | 0.77394923 |
| 144 | MP0002933_joint_inflammation | 0.76907278 |
| 145 | MP0002160_abnormal_reproductive_system | 0.76282646 |
| 146 | MP0004808_abnormal_hematopoietic_stem | 0.75692741 |
| 147 | MP0003191_abnormal_cellular_cholesterol | 0.75645744 |
| 148 | MP0005220_abnormal_exocrine_pancreas | 0.74118202 |
| 149 | MP0005075_abnormal_melanosome_morpholog | 0.71892658 |
| 150 | MP0005395_other_phenotype | 0.71755961 |
| 151 | MP0009763_increased_sensitivity_to | 0.71738751 |
| 152 | MP0003122_maternal_imprinting | 0.70954402 |
| 153 | MP0009642_abnormal_blood_homeostasis | 0.70928116 |
| 154 | MP0002909_abnormal_adrenal_gland | 0.69443949 |
| 155 | MP0005376_homeostasis/metabolism_phenot | 0.69355952 |
| 156 | MP0005408_hypopigmentation | 0.69092599 |
| 157 | MP0005166_decreased_susceptibility_to | 0.67787962 |
| 158 | MP0000858_altered_metastatic_potential | 0.67333058 |
| 159 | MP0005266_abnormal_metabolism | 0.66055494 |
| 160 | MP0003698_abnormal_male_reproductive | 0.64824022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the anterior horn cell (HP:0006802) | 3.82736217 |
| 2 | Degeneration of anterior horn cells (HP:0002398) | 3.82736217 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 3.74107519 |
| 4 | Poor head control (HP:0002421) | 3.69827053 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.60017821 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.53730731 |
| 7 | Acute encephalopathy (HP:0006846) | 3.51112571 |
| 8 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.39142550 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.39142550 |
| 10 | Progressive macrocephaly (HP:0004481) | 3.25093482 |
| 11 | Increased serum pyruvate (HP:0003542) | 3.23201671 |
| 12 | Generalized aminoaciduria (HP:0002909) | 3.22238554 |
| 13 | Hypothermia (HP:0002045) | 3.13587372 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 3.11330232 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.09553381 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.09238625 |
| 17 | Renal Fanconi syndrome (HP:0001994) | 2.98999898 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 2.94117375 |
| 19 | Abnormality of macular pigmentation (HP:0008002) | 2.93909777 |
| 20 | Abnormality of macrophages (HP:0004311) | 2.90259232 |
| 21 | Beaking of vertebral bodies (HP:0004568) | 2.89197718 |
| 22 | Cerebral edema (HP:0002181) | 2.87863122 |
| 23 | Abnormality of glycolysis (HP:0004366) | 2.85280268 |
| 24 | Methylmalonic acidemia (HP:0002912) | 2.84968933 |
| 25 | Abnormal spermatogenesis (HP:0008669) | 2.79731094 |
| 26 | Irregular epiphyses (HP:0010582) | 2.77415387 |
| 27 | Dicarboxylic aciduria (HP:0003215) | 2.76930838 |
| 28 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76930838 |
| 29 | Azoospermia (HP:0000027) | 2.76407458 |
| 30 | Respiratory failure (HP:0002878) | 2.76154434 |
| 31 | Hypoglycemic coma (HP:0001325) | 2.74256657 |
| 32 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.72573222 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.71982896 |
| 34 | Severe visual impairment (HP:0001141) | 2.69157848 |
| 35 | Congenital stationary night blindness (HP:0007642) | 2.67973962 |
| 36 | Abolished electroretinogram (ERG) (HP:0000550) | 2.67724249 |
| 37 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.65515208 |
| 38 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.65515208 |
| 39 | Abnormal protein glycosylation (HP:0012346) | 2.65515208 |
| 40 | Abnormal glycosylation (HP:0012345) | 2.65515208 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.63765877 |
| 42 | Methylmalonic aciduria (HP:0012120) | 2.63070734 |
| 43 | Hypobetalipoproteinemia (HP:0003563) | 2.62921080 |
| 44 | Aplastic anemia (HP:0001915) | 2.59855468 |
| 45 | Exercise intolerance (HP:0003546) | 2.59457975 |
| 46 | Hepatic necrosis (HP:0002605) | 2.56085971 |
| 47 | Lethargy (HP:0001254) | 2.56033973 |
| 48 | Agnosia (HP:0010524) | 2.55125995 |
| 49 | True hermaphroditism (HP:0010459) | 2.53111436 |
| 50 | Acute myeloid leukemia (HP:0004808) | 2.51917583 |
| 51 | Tubulointerstitial nephritis (HP:0001970) | 2.50743458 |
| 52 | Exertional dyspnea (HP:0002875) | 2.50076064 |
| 53 | Glycosuria (HP:0003076) | 2.49871454 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 2.49871454 |
| 55 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.48057290 |
| 56 | Hepatocellular necrosis (HP:0001404) | 2.46694773 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.44487535 |
| 58 | Chronic otitis media (HP:0000389) | 2.42984954 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.42866907 |
| 60 | Palpitations (HP:0001962) | 2.41248969 |
| 61 | Hyperglycinemia (HP:0002154) | 2.35708820 |
| 62 | Pancreatic fibrosis (HP:0100732) | 2.35112012 |
| 63 | Prolonged neonatal jaundice (HP:0006579) | 2.33648500 |
| 64 | CNS demyelination (HP:0007305) | 2.32872937 |
| 65 | Type 2 muscle fiber atrophy (HP:0003554) | 2.30457667 |
| 66 | Central scotoma (HP:0000603) | 2.25672754 |
| 67 | Spastic paraparesis (HP:0002313) | 2.25478179 |
| 68 | Rhabdomyolysis (HP:0003201) | 2.24372155 |
| 69 | Pancreatic cysts (HP:0001737) | 2.23564552 |
| 70 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21531705 |
| 71 | Hyperammonemia (HP:0001987) | 2.18466379 |
| 72 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.15740237 |
| 73 | Poor coordination (HP:0002370) | 2.15694185 |
| 74 | Interstitial pulmonary disease (HP:0006530) | 2.14328896 |
| 75 | Opisthotonus (HP:0002179) | 2.13924810 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12136070 |
| 77 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.11860118 |
| 78 | Glucose intolerance (HP:0000833) | 2.11635868 |
| 79 | Nonprogressive disorder (HP:0003680) | 2.11017381 |
| 80 | Abnormality of the fovea (HP:0000493) | 2.09370660 |
| 81 | Respiratory difficulties (HP:0002880) | 2.08559067 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.08057661 |
| 83 | B lymphocytopenia (HP:0010976) | 2.08057661 |
| 84 | Deep venous thrombosis (HP:0002625) | 2.06914817 |
| 85 | Hypoproteinemia (HP:0003075) | 2.05707818 |
| 86 | Carpal bone hypoplasia (HP:0001498) | 2.05090450 |
| 87 | Abnormality of serum amino acid levels (HP:0003112) | 2.04321249 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.03932041 |
| 89 | Proximal tubulopathy (HP:0000114) | 2.03853130 |
| 90 | Congenital primary aphakia (HP:0007707) | 2.03222119 |
| 91 | Abnormality of vitamin B metabolism (HP:0004340) | 2.01642184 |
| 92 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.01616027 |
| 93 | Patchy hypopigmentation of hair (HP:0011365) | 2.01331802 |
| 94 | Abnormality of glycine metabolism (HP:0010895) | 2.00735300 |
| 95 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.00735300 |
| 96 | Hypokinesia (HP:0002375) | 1.98365502 |
| 97 | Retinal dysplasia (HP:0007973) | 1.98288059 |
| 98 | Metaphyseal dysplasia (HP:0100255) | 1.98108183 |
| 99 | Nausea (HP:0002018) | 1.97673620 |
| 100 | Flat capital femoral epiphysis (HP:0003370) | 1.97404856 |
| 101 | Renal cortical cysts (HP:0000803) | 1.97222427 |
| 102 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96475050 |
| 103 | IgM deficiency (HP:0002850) | 1.96236036 |
| 104 | Increased serum lactate (HP:0002151) | 1.96104775 |
| 105 | Abnormal pupillary function (HP:0007686) | 1.95510799 |
| 106 | Petechiae (HP:0000967) | 1.95299559 |
| 107 | Mitochondrial inheritance (HP:0001427) | 1.94497970 |
| 108 | Abnormality of the common coagulation pathway (HP:0010990) | 1.94234731 |
| 109 | Joint hemorrhage (HP:0005261) | 1.93478607 |
| 110 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.92796371 |
| 111 | Hypoplasia of the fovea (HP:0007750) | 1.92796371 |
| 112 | Cerebral palsy (HP:0100021) | 1.91542966 |
| 113 | Hyperglycinuria (HP:0003108) | 1.91328215 |
| 114 | Microretrognathia (HP:0000308) | 1.91215633 |
| 115 | Muscle fiber atrophy (HP:0100295) | 1.90123462 |
| 116 | Nephrogenic diabetes insipidus (HP:0009806) | 1.89740437 |
| 117 | Increased CSF lactate (HP:0002490) | 1.87298027 |
| 118 | Rough bone trabeculation (HP:0100670) | 1.86567476 |
| 119 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85717570 |
| 120 | Abnormality of alanine metabolism (HP:0010916) | 1.85717570 |
| 121 | Hyperalaninemia (HP:0003348) | 1.85717570 |
| 122 | Lipid accumulation in hepatocytes (HP:0006561) | 1.85610112 |
| 123 | Hyperglycemia (HP:0003074) | 1.85017868 |
| 124 | Vertebral compression fractures (HP:0002953) | 1.83565070 |
| 125 | Pancytopenia (HP:0001876) | 1.83518761 |
| 126 | Exercise-induced muscle cramps (HP:0003710) | 1.83212944 |
| 127 | Microvesicular hepatic steatosis (HP:0001414) | 1.83177648 |
| 128 | Progressive neurologic deterioration (HP:0002344) | 1.81962249 |
| 129 | Myoglobinuria (HP:0002913) | 1.81689360 |
| 130 | Emotional lability (HP:0000712) | 1.80999774 |
| 131 | Increased hepatocellular lipid droplets (HP:0006565) | 1.80955686 |
| 132 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80177945 |
| 133 | Hyperphosphaturia (HP:0003109) | 1.80109065 |
| 134 | Sensorimotor neuropathy (HP:0007141) | 1.80073856 |
| 135 | Myositis (HP:0100614) | 1.79600361 |
| 136 | Stenosis of the external auditory canal (HP:0000402) | 1.79114356 |
| 137 | Increased IgM level (HP:0003496) | 1.78781230 |
| 138 | 3-Methylglutaconic aciduria (HP:0003535) | 1.76885883 |
| 139 | Eczematoid dermatitis (HP:0000976) | 1.76677510 |
| 140 | Epiphyseal stippling (HP:0010655) | 1.76388564 |
| 141 | Abnormal gallbladder physiology (HP:0012438) | 1.75909186 |
| 142 | Cholecystitis (HP:0001082) | 1.75909186 |
| 143 | Gait imbalance (HP:0002141) | 1.75069676 |
| 144 | Pigmentary retinal degeneration (HP:0001146) | 1.74873069 |
| 145 | Genu varum (HP:0002970) | 1.74579017 |
| 146 | Postaxial foot polydactyly (HP:0001830) | 1.73884485 |
| 147 | Metabolic acidosis (HP:0001942) | 1.73631119 |
| 148 | Increased muscle lipid content (HP:0009058) | 1.70504969 |
| 149 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.69870968 |
| 150 | Lactic acidosis (HP:0003128) | 1.69716671 |
| 151 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69551269 |
| 152 | Vitreoretinal degeneration (HP:0000655) | 1.69439206 |
| 153 | Abnormality of the pons (HP:0007361) | 1.67627260 |
| 154 | Neoplasm of the adrenal gland (HP:0100631) | 1.67497894 |
| 155 | Birth length less than 3rd percentile (HP:0003561) | 1.67069225 |
| 156 | Granulocytopenia (HP:0001913) | 1.66402298 |
| 157 | Abnormal trabecular bone morphology (HP:0100671) | 1.66343271 |
| 158 | Dysostosis multiplex (HP:0000943) | 1.65789305 |
| 159 | Recurrent pneumonia (HP:0006532) | 1.65234269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 4.76334290 |
| 2 | STK16 | 3.78705464 |
| 3 | PBK | 3.48888774 |
| 4 | MAPKAPK3 | 3.23076867 |
| 5 | EIF2AK1 | 2.71820412 |
| 6 | ACVR1B | 2.57488763 |
| 7 | MYLK | 2.42717872 |
| 8 | VRK2 | 2.40593354 |
| 9 | WEE1 | 2.34540769 |
| 10 | BUB1 | 2.30765028 |
| 11 | TLK1 | 2.20346560 |
| 12 | MAP4K2 | 2.14807491 |
| 13 | FLT3 | 2.12826997 |
| 14 | TRIM28 | 2.01711063 |
| 15 | SCYL2 | 1.98973796 |
| 16 | NME2 | 1.89055384 |
| 17 | BRSK2 | 1.82431397 |
| 18 | PDK2 | 1.81436343 |
| 19 | NEK2 | 1.80859621 |
| 20 | PIM2 | 1.80599730 |
| 21 | EIF2AK3 | 1.77937500 |
| 22 | TXK | 1.70453462 |
| 23 | CDK19 | 1.68007865 |
| 24 | PLK4 | 1.66212358 |
| 25 | TEC | 1.65379387 |
| 26 | RPS6KB2 | 1.63362492 |
| 27 | MAP4K1 | 1.62140146 |
| 28 | TRPM7 | 1.61133629 |
| 29 | PRKG2 | 1.57846533 |
| 30 | MST4 | 1.52503504 |
| 31 | VRK1 | 1.51475846 |
| 32 | KIT | 1.51461641 |
| 33 | ARAF | 1.50309596 |
| 34 | MAPKAPK5 | 1.48476774 |
| 35 | BCR | 1.48285246 |
| 36 | ZAP70 | 1.42946275 |
| 37 | BCKDK | 1.32567600 |
| 38 | FRK | 1.30775380 |
| 39 | TESK1 | 1.25923721 |
| 40 | EEF2K | 1.25569985 |
| 41 | PAK4 | 1.25044921 |
| 42 | PIK3CA | 1.22410564 |
| 43 | CAMKK2 | 1.20278438 |
| 44 | IKBKE | 1.18470045 |
| 45 | ILK | 1.15315685 |
| 46 | MUSK | 1.14599697 |
| 47 | BRAF | 1.13622117 |
| 48 | RPS6KA4 | 1.13134206 |
| 49 | TYK2 | 1.12888865 |
| 50 | MAP3K14 | 1.12653289 |
| 51 | CDK8 | 1.12345957 |
| 52 | PLK2 | 1.12101345 |
| 53 | DAPK1 | 1.11526985 |
| 54 | TBK1 | 1.11249829 |
| 55 | PINK1 | 1.06641578 |
| 56 | TTK | 1.05925183 |
| 57 | CSNK1G3 | 1.02059548 |
| 58 | GRK1 | 1.00765008 |
| 59 | BMPR1B | 1.00391588 |
| 60 | MKNK1 | 0.97092866 |
| 61 | BMPR2 | 0.95349467 |
| 62 | ADRBK2 | 0.94813071 |
| 63 | LMTK2 | 0.91211005 |
| 64 | MOS | 0.90027192 |
| 65 | ZAK | 0.89883127 |
| 66 | CSNK1G1 | 0.89644623 |
| 67 | IRAK4 | 0.89282734 |
| 68 | PIK3CG | 0.89189049 |
| 69 | PASK | 0.88910587 |
| 70 | TNK2 | 0.88603588 |
| 71 | STK39 | 0.88141107 |
| 72 | JAK3 | 0.86510285 |
| 73 | NME1 | 0.84535729 |
| 74 | SIK3 | 0.83011528 |
| 75 | NEK9 | 0.82735536 |
| 76 | EIF2AK2 | 0.81195381 |
| 77 | CHEK2 | 0.80741226 |
| 78 | DAPK3 | 0.79776069 |
| 79 | NLK | 0.78246540 |
| 80 | DYRK3 | 0.77962919 |
| 81 | IKBKB | 0.75105073 |
| 82 | PLK1 | 0.74982378 |
| 83 | ERBB3 | 0.74678963 |
| 84 | CSNK1G2 | 0.74091235 |
| 85 | CSF1R | 0.73177400 |
| 86 | OXSR1 | 0.69509070 |
| 87 | TIE1 | 0.68699959 |
| 88 | STK4 | 0.68260931 |
| 89 | TGFBR2 | 0.67986972 |
| 90 | TESK2 | 0.67525005 |
| 91 | TAOK3 | 0.67097243 |
| 92 | SYK | 0.66954285 |
| 93 | LIMK1 | 0.66479453 |
| 94 | BTK | 0.64642558 |
| 95 | BRSK1 | 0.63897215 |
| 96 | CSNK1A1L | 0.63828118 |
| 97 | ATR | 0.62338457 |
| 98 | WNK4 | 0.61507800 |
| 99 | CDC7 | 0.60974907 |
| 100 | PHKG1 | 0.59219018 |
| 101 | PHKG2 | 0.59219018 |
| 102 | PIM1 | 0.58373911 |
| 103 | PLK3 | 0.58088289 |
| 104 | STK38L | 0.57562133 |
| 105 | MAP3K11 | 0.55940545 |
| 106 | MAPK15 | 0.55522637 |
| 107 | LYN | 0.55461559 |
| 108 | BLK | 0.55408407 |
| 109 | MAPK11 | 0.55018248 |
| 110 | TNIK | 0.54671002 |
| 111 | ERBB4 | 0.53561161 |
| 112 | PDK3 | 0.52928183 |
| 113 | PDK4 | 0.52928183 |
| 114 | CDK7 | 0.52913679 |
| 115 | WNK3 | 0.52678780 |
| 116 | STK3 | 0.52075703 |
| 117 | NUAK1 | 0.50835749 |
| 118 | CSNK2A1 | 0.50577569 |
| 119 | EPHA3 | 0.50562690 |
| 120 | MAP2K6 | 0.50429458 |
| 121 | MET | 0.50176794 |
| 122 | ABL2 | 0.50080235 |
| 123 | CHUK | 0.49986711 |
| 124 | FER | 0.49062441 |
| 125 | RAF1 | 0.48972860 |
| 126 | PRKCE | 0.48748175 |
| 127 | AURKA | 0.47933327 |
| 128 | PAK1 | 0.47928084 |
| 129 | MAP3K12 | 0.47401290 |
| 130 | AURKB | 0.46380588 |
| 131 | MKNK2 | 0.45428796 |
| 132 | RPS6KA5 | 0.45019170 |
| 133 | DYRK2 | 0.44784161 |
| 134 | STK24 | 0.44055470 |
| 135 | CCNB1 | 0.44008323 |
| 136 | CSNK2A2 | 0.43350209 |
| 137 | GRK7 | 0.43150063 |
| 138 | MAP3K5 | 0.42522172 |
| 139 | MST1R | 0.42079630 |
| 140 | PTK2 | 0.41982043 |
| 141 | KDR | 0.40669494 |
| 142 | EPHA2 | 0.39961699 |
| 143 | STK10 | 0.39053873 |
| 144 | SRPK1 | 0.37524452 |
| 145 | MINK1 | 0.37496335 |
| 146 | CAMK2D | 0.35491709 |
| 147 | IGF1R | 0.34549334 |
| 148 | GRK5 | 0.33366581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.54196888 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.41425911 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.10173962 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.98523171 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.53161699 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.53142176 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.48091367 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.41622741 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.40534571 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.35155001 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31297874 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.28073706 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.22863438 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.20704327 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03935930 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.03878017 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.96266635 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.94401861 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.92788119 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85018989 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.83224547 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.81318106 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.80158639 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76154720 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.74971599 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.72816703 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.61486248 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60209333 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58659291 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.56378851 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.49059764 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.48845415 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.47966647 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.44876536 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44389752 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.39840257 |
| 37 | Cell cycle_Homo sapiens_hsa04110 | 1.38198419 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37763442 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34382598 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.34167651 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31963901 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 1.29489794 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.27884503 |
| 44 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.27356773 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27052104 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.25432663 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.22288867 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.22016401 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20756171 |
| 50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17955198 |
| 51 | Spliceosome_Homo sapiens_hsa03040 | 1.15135061 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14580207 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12360318 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.11482191 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10722216 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09925363 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08824752 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.08760072 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07843338 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 1.06934885 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04254285 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03929656 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03770088 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 1.00467322 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96824111 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94886380 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.92611516 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90398128 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89028950 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88271223 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88128126 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87470880 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85849976 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84468665 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84018345 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81419551 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81261668 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80912517 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79537233 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78988061 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77279145 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75861956 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.74650586 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72706894 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72130570 |
| 86 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71915755 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69976093 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68684842 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66570241 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66381290 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65406065 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65227638 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65137872 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64930691 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64141978 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63864250 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63459650 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62723911 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.60578105 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60320163 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59516211 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56374300 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55673701 |
| 104 | Allograft rejection_Homo sapiens_hsa05330 | 0.53311824 |
| 105 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51843206 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51842282 |
| 107 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51415783 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51345525 |
| 109 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50793572 |
| 110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50154124 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49208094 |
| 112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49136668 |
| 113 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48195149 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47902835 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.47794371 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46849545 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46456009 |
| 118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45940376 |
| 119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44141458 |
| 120 | Influenza A_Homo sapiens_hsa05164 | 0.44056087 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43910581 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43572998 |
| 123 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.43355358 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42903436 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41933296 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41791725 |
| 127 | Asthma_Homo sapiens_hsa05310 | 0.41460299 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40778721 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39526962 |
| 130 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38850064 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38772078 |
| 132 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38265759 |
| 133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37312337 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37031604 |
| 135 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.36689658 |

